BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 27665128)

  • 21. Insight Into a Novel Strategy for the Design of Tablet Formulations Intended for Direct Compression.
    Capece M; Huang Z; Davé R
    J Pharm Sci; 2017 Jun; 106(6):1608-1617. PubMed ID: 28283431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Commercial scale validation of a process scale-up model for lubricant blending of pharmaceutical powders.
    Kushner J; Schlack H
    Int J Pharm; 2014 Nov; 475(1-2):147-55. PubMed ID: 25152166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lubricant based determination of design space for continuously manufactured high dose paracetamol tablets.
    Taipale-Kovalainen K; Karttunen AP; Ketolainen J; Korhonen O
    Eur J Pharm Sci; 2018 Mar; 115():1-10. PubMed ID: 29277668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface engineered excipients: III. Facilitating direct compaction tableting of binary blends containing fine cohesive poorly-compactable APIs.
    Chen L; He Z; Kunnath KT; Fan S; Wei Y; Ding X; Zheng K; Davé RN
    Int J Pharm; 2019 Feb; 557():354-365. PubMed ID: 30597273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Coprocessed Chitin-Calcium Carbonate as Multifunctional Tablet Excipient for Direct Compression.
    Chaheen M; Sanchez-Ballester NM; Bataille B; Yassine A; Belamie E; Sharkawi T
    J Pharm Sci; 2018 Aug; 107(8):2152-2159. PubMed ID: 29698724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic evaluation of poloxamers as tablet lubricants.
    Dun J; Osei-Yeboah F; Boulas P; Lin Y; Sun CC
    Int J Pharm; 2020 Feb; 576():118994. PubMed ID: 31893543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of tablet hardness based on near infrared spectra of raw mixed powders by chemometrics.
    Otsuka M; Yamane I
    J Pharm Sci; 2006 Jul; 95(7):1425-33. PubMed ID: 16721793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of processing methods on physico-mechanical properties of Ibuprofen/HPC-SSL formulation.
    Chaturvedi K; Gajera BY; Xu T; Shah H; Dave RH
    Pharm Dev Technol; 2018 Dec; 23(10):1108-1116. PubMed ID: 29310491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of flow and bulk density of pharmaceutical powders using surface modification.
    Jallo LJ; Ghoroi C; Gurumurthy L; Patel U; Davé RN
    Int J Pharm; 2012 Feb; 423(2):213-25. PubMed ID: 22197769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of selected micronized poloxamers as tablet lubricants.
    Desai D; Zia H; Quadir A
    Drug Deliv; 2007 Oct; 14(7):413-26. PubMed ID: 17994358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
    Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
    Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
    Gohel M; Parikh R; Brahmbhatt B; Shah A
    AAPS PharmSciTech; 2007 Feb; 8(1):13. PubMed ID: 17408213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and process optimization to eliminate picking from market image tablets.
    Sabir A; Evans B; Jain S
    Int J Pharm; 2001 Mar; 215(1-2):123-35. PubMed ID: 11250098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vegetable-derived magnesium stearate functionality evaluation by DM(3) approach.
    Haware RV; Dave VS; Kakarala B; Delaney S; Staton S; Munson E; Gupta MR; Stagner WC
    Eur J Pharm Sci; 2016 Jun; 89():115-24. PubMed ID: 27108117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excipient-process interactions and their impact on tablet compaction and film coating.
    Pandey P; Bindra DS; Gour S; Trinh J; Buckley D; Badawy S
    J Pharm Sci; 2014 Nov; 103(11):3666-3674. PubMed ID: 25223603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating critical effects of variegated lubricants, glidants and hydrophilic additives on lag time of press coated ethylcellulose tablets.
    Patadia R; Vora C; Mittal K; Mashru R
    Pharm Dev Technol; 2016; 21(3):302-10. PubMed ID: 25566928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
    Patel N; Madan P; Lin S
    Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic evaluation of common lubricants for optimal use in tablet formulation.
    Paul S; Sun CC
    Eur J Pharm Sci; 2018 May; 117():118-127. PubMed ID: 29432807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hexagonal boron nitride as a tablet lubricant and a comparison with conventional lubricants.
    Uğurlu T; Turkoğlu M
    Int J Pharm; 2008 Apr; 353(1-2):45-51. PubMed ID: 18160235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluidity and tableting characteristics of a powder solid dispersion of the low melting drugs ketoprofen and ibuprofen with crospovidone.
    Shibata Y; Fujii M; Noda S; Kokudai M; Okada H; Kondoh M; Watanabe Y
    Drug Dev Ind Pharm; 2006 Apr; 32(4):449-56. PubMed ID: 16638683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.